αTAT1: a potential therapeutic target in cancer?

Cell Death Dis. 2016 Mar 31;7(3):e2172. doi: 10.1038/cddis.2016.46.

Authors

J-Y Chien¹, C-H Lin^{1

2

3

4}

Affiliations

¹ Institute of Microbiology and Immunology, National Yang-Ming University, Taipei, Taiwan.
² Institute of Biophotonics, National Yang-Ming University, Taipei, Taiwan.
³ Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
⁴ VYM Genome Research Center, National Yang-Ming University, Taipei, Taiwan.

No abstract available

Publication types

News

MeSH terms

A549 Cells
Acetylation
Acetyltransferases / antagonists & inhibitors
Acetyltransferases / genetics
Acetyltransferases / metabolism*
Down-Regulation
HeLa Cells
Humans
Neoplasms / drug therapy
Neoplasms / metabolism
Neoplasms / pathology
RNA Interference
RNA, Small Interfering / metabolism
RNA, Small Interfering / therapeutic use
Time-Lapse Imaging
Tubulin / metabolism

Substances

RNA, Small Interfering
Tubulin
Acetyltransferases
alpha-tubulin acetylase